USFDA Archives - Express Pharma

Addressing US FDA challenges in Indian sterile drug manufacturing – Part 3

Addressing US FDA challenges in Indian sterile drug manufacturing – Part 2

What the new drug rules mean for quality control in Pharma: From lab to license

Alembic gains USFDA final approval for Amlodipine & Atorvastatin Tablets USP, 2.5 mg/10 mg, 2.5 mg/20 mg, 2.5 mg/40 mg, 5 mg/10 mg, 5 mg/20 mg, 5 mg/40 mg, 5 mg/80 mg, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg, & 10 mg/80 mg

Indoco Remedies gains USFDA final approval for Allopurinol Tablets USP 200 mg

Lupin gains USFDA approval for Rivaroxaban Tablets USP, 10 mg, 15 mg, and 20 mg

Lupin launches Tolvaptan Tablets in the US

Lupin gains USFDA nod for Raltegravir Tablets USP, 600 mg

FDA approves trial to advance treatment for Hereditary Spastic Paraplegia (HSP)

Strides Pharma receives USFDA approval for Celecoxib Capsules in multiple strengths

	
		OSZAR »

	
		OSZAR »